Literature DB >> 17603543

Alpha1-adrenoceptors and ejaculatory function.

M C Michel1.   

Abstract

The abnormal ejaculation of semen is a typical but infrequent side effect of some alpha(1)-adrenoceptor antagonists, particularly those with selectivity for alpha(1A)-adrenoceptors such as silodosin or tamsulosin. Recent clinical studies suggest that this represents a relative anejaculation rather than a retrograde ejaculation. An elegant study in this issue of the journal using alpha(1A) single and alpha(1A/B/D) triple knock-out mice reports a similar phenomenon in rodents. Using a multi-disciplinary approach, the reduced ejaculation and related male infertility is shown to be caused by an impaired function of the vas deferens rather than by alterations in sperm formation, number or function. Similarities and differences between mouse and human data are discussed, particularly why a complete inhibition of all three alpha(1)-adrenoceptor subtypes has the strongest effects in mice whereas apparently only alpha(1A)-adrenoceptor-selective drugs impair ejaculatory function in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603543      PMCID: PMC2042961          DOI: 10.1038/sj.bjp.0707369

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Alpha1-adrenoceptors are required for normal male sexual function.

Authors:  A Sanbe; Y Tanaka; Y Fujiwara; H Tsumura; J Yamauchi; S Cotecchia; K Koike; G Tsujimoto; A Tanoue
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

2.  Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.

Authors:  François A Giuliano; Pierre Clément; Pierre Denys; Laurent Alexandre; Jacques Bernabé
Journal:  BJU Int       Date:  2006-07-28       Impact factor: 5.588

3.  Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.

Authors:  Shin-ichi Hisasue; Ryoji Furuya; Naoki Itoh; Ko Kobayashi; Seiji Furuya; Taiji Tsukamoto
Journal:  Int J Urol       Date:  2006-10       Impact factor: 3.369

4.  In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.

Authors:  M Eltze; R Boer; M C Michel; P Hein; R Testa; W R Ulrich; N Kolassa; K H Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-06       Impact factor: 3.000

5.  Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.

Authors:  K Taguchi; R F Schäfers; M C Michel
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

6.  Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.

Authors:  A Leonardi; J P Hieble; L Guarneri; D P Naselsky; E Poggesi; G Sironi; A C Sulpizio; R Testa
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

7.  Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.

Authors:  Wayne J G Hellstrom; Suresh C Sikka
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

8.  The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.

Authors:  A J Noble; R Chess-Williams; C Couldwell; K Furukawa; T Uchyiuma; C Korstanje; C R Chapple
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

9.  Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle.

Authors:  M C Michel; G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

Review 10.  Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Authors:  Marleen M van Dijk; Jean J M C H de la Rosette; Martin C Michel
Journal:  Drugs       Date:  2006       Impact factor: 9.546

  10 in total
  14 in total

Review 1.  Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.

Authors:  Yoshiyuki Kojima; Shoichi Sasaki; Yutaro Hayashi; Gozoh Tsujimoto; Kenjiro Kohri
Journal:  Nat Clin Pract Urol       Date:  2009-01

2.  Side Effects of alpha-Blocker Use: Retrograde Ejaculation.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2009

3.  Sperm chromosomal aneuploidy and DNA integrity of infertile men with anejaculation.

Authors:  Yi Qiu; Lei-Guang Wang; Li-Hong Zhang; Juan Li; Ai-Dong Zhang; Mei-Hua Zhang
Journal:  J Assist Reprod Genet       Date:  2012-01-04       Impact factor: 3.412

4.  Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.

Authors:  Erkan Karadağ; Sedat Öner; Yasemin U Budak; Özcan Atahan
Journal:  Int Urol Nephrol       Date:  2011-04-08       Impact factor: 2.370

Review 5.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

Review 6.  Silodosin in the treatment of benign prostatic hyperplasia.

Authors:  Maxime Rossi; Thierry Roumeguère
Journal:  Drug Des Devel Ther       Date:  2010-10-27       Impact factor: 4.162

7.  Benign prostatic hyperplasia: from bench to clinic.

Authors:  Tag Keun Yoo; Hee Ju Cho
Journal:  Korean J Urol       Date:  2012-03-19

8.  Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.

Authors:  C G Roehrborn; S A Kaplan; H Lepor; W Volinn
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-12-07       Impact factor: 5.554

Review 9.  Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Authors:  Masaki Yoshida; Junzo Kudoh; Yukio Homma; Kazuki Kawabe
Journal:  Clin Interv Aging       Date:  2011-06-22       Impact factor: 4.458

Review 10.  Management of benign prostatic hyperplasia with silodosin.

Authors:  Tomonori Yamanishi; Tomoya Mizuno; Takao Kamai; Ken-Ichiro Yoshida; Ryuji Sakakibara; Tomoyuki Uchiyama
Journal:  Open Access J Urol       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.